Amantadine - A Fatigue Reducer for Long COVID and ME/CFS?
- Condition
- ME/CFS
- At worst
- Not stated
- Ill for
- 1 year
- Published
- Jan 2024
Summary
Amantadine, tried at an unspecified dose about a year into her ME/CFS. No further detail on total illness duration or severity is given in her comment. She reports it "was no help at all" for her fatigue or other core symptoms. She adds that it actively worsened her POTS by increasing adrenaline-type symptoms, making it a net negative rather than simply ineffective. No benefit, relapse-after-improvement, or maintenance use is described, since no improvement occurred in the first place.
Similar stories
-
Amantadine - A Fatigue Reducer for Long COVID and ME/CFS?
Amantadine, tried in 2003 at an unspecified dose for her ME/CFS. Her illness duration and severity beforehand are not stated in her comment. She reports it "never helped and did nothing for me," describing no improvement in fatigue or other symptoms. She…
-
Beginning of improvement?
Six weeks into a self-directed antiviral/immune-booster stack (famciclovir, amantadine, cimetidine, astragalus, inosine, vitamin C) for CFS that began after an unresolved flu six years earlier, reports "much more energy, no brain fog, no fatigue, no chest…